Study links America’s favorite cooking oil to obesity
November 26, 2025 / Soybean oil / Obesity risk / Linoleic acid / Oxylipins metabolism / Fatty liver
UC Riverside researchers found that high soybean oil intake promotes obesity in mice by increasing liver-derived oxylipins, molecules tied to fat accumulation and inflammation, suggesting individual metabolic responses and enzyme variability may mediate risk in humans.
Fat sensory cues in early life program central response to food and obesity
December 1, 2025 / Maternal obesity / Fat sensory cues / Metabolic programming / Childhood obesity / Dopaminergic circuits
Early-life exposure to fat-related sensory cues—independent of calorie intake—alters brain circuits regulating hunger and metabolism, predisposing offspring to obesity and metabolic inflexibility when later exposed to high-fat diets, regardless of maternal metabolic health.
The surprising connection between obesity, choline and brain inflammation
November 25, 2025 / Obesity inflammation / Choline deficiency / Brain health / Cognitive decline / Neurodegeneration markers
Researchers found that young adults with obesity show early signs of brain inflammation and neuronal damage, linked to low choline levels—a nutrient vital for liver and brain health—highlighting a potential metabolic-brain connection well before cognitive symptoms appear.
How the gut microbiome links obesity to colorectal cancer
November 28, 2025 / Gut microbiome / Obesity cancer link / Colorectal cancer / Microbial metabolites / Inflammation pathway
This review highlights how gut microbiome imbalances in obesity contribute to colorectal cancer via inflammation, microbial metabolites, and immune signaling, underscoring the microbiome’s emerging role as both a biomarker and therapeutic target for metabolic and cancer prevention strategies.
Undiagnosed Klinefelter Linked to Worse Metabolic Health
November 25, 2025 / Klinefelter syndrome / Testosterone therapy / Metabolic health / Type 2 diabetes / Early diagnosis
Undiagnosed Klinefelter syndrome is linked to significantly worse metabolic health, including severe obesity and advanced diabetes complications, compared to diagnosed cases—highlighting the critical need for early detection and testosterone therapy to reduce morbidity and improve outcomes.
Scientists create a drug that allows you to eat junk food without gaining weight
December 1, 2025 / Obesity treatment / Mitochondrial magnesium / Weight loss drug / Fat metabolism / CPACC therapy
Researchers developed CPACC, a magnesium transport blocker, which prevented weight gain and liver damage in mice on a junk-food diet by enhancing fat and sugar metabolism—offering a potential future therapy for obesity and metabolic disease, pending human trials.
Smelling Fatty Foods in Pregnancy May Raise Obesity Risk in Children
December 1, 2025 / Prenatal nutrition / Fatty food odors / Childhood obesity / Brain circuit changes / Metabolic programming
Prenatal and early-life exposure to fatty food odors can rewire brain circuits that control hunger and reward, increasing the risk of obesity and insulin resistance in offspring—even when maternal diet remains healthy and low in fat.
Analyst Sees Value In Neumora’s Expanding Obesity And Metabolic Pipeline
December 1, 2025 / Neumora Therapeutics / Obesity pipeline / Metabolic disorders / Biotech investment / Pipeline expansion
Neumora Therapeutics is expanding its pipeline into obesity and metabolic disorders, prompting a rating upgrade from RBC Capital Markets, which sees undervalued growth potential beyond the company’s neurology focus.
Does Weight Loss Always Mean Muscle Loss? Study on Wegovy Patients Reveals a Twist
November 26, 2025 / Wegovy weight loss / Muscle preservation / Sarcopenic obesity / Semaglutide study / Fat reduction
A year-long real-world study shows Wegovy promotes fat-focused weight loss while largely preserving muscle mass and improving muscle function in severely obese patients, challenging the belief that weight loss inevitably leads to sarcopenia or reduced metabolic efficiency.
Noninvasive Test Shows Accuracy for Detecting Advanced Liver Fibrosis in MASH
November 28, 2024 / MASH fibrosis / BMP8A biomarker / Noninvasive testing / Liver fibrosis score / Fibrosis detection
The BMP8A Fibrosis Score more accurately identifies advanced fibrosis in MASH and removes grey‑zone ambiguity, outperforming standard noninvasive tests and offering clearer stratification for clinical decisions and trial screening, though broader validation and assay availability remain needed.
Artificial Sweetener Sorbitol May Drive Liver Disease
December 1, 2025 / Sorbitol risks / Fatty liver disease / Artificial sweeteners / Fructose metabolism / MASLD progression
New zebrafish data show sorbitol converts to a fructose‑like metabolite that can drive MASLD/MASH, especially when gut bacteria cannot degrade excess sorbitol—highlighting metabolic and liver risks from artificial sweeteners, particularly in people with diabetes.
Metabolic Syndrome Symptoms That Raise Heart Attack and Stroke Risk—Especially After 50
December 1, 2025 / Metabolic syndrome / Cardiometabolic risk / Silent symptoms / Aging and obesity / Heart disease prevention
Metabolic syndrome—a largely silent cluster of cardiometabolic risk factors—rises sharply after age 50 and significantly increases heart attack, stroke, and diabetes risk, underscoring the importance of early detection, lifestyle intervention, and appropriate medical management.
Bile acids segregate metabolic syndrome in a cohort of 100 deeply phenotyped horses
November 27, 2025 / Metabolic syndrome / Bile acids / Insulin resistance / Equine model / Precision medicine
A multi-omic study in horses identified bile acids, particularly taurocholic acid, as key biomarkers linked to insulin resistance in metabolic syndrome, reinforcing the horse as a translational model for understanding human MetS and advancing precision diagnostics.
Metabolites produced in the intestine play a central role in controlling obesity and diabetes
November 26, 2025 / Gut microbiome / Insulin resistance / Liver metabolism / Metabolic disease / Type 2 diabetes
Harvard-led research identified gut-derived metabolites that influence liver metabolism and insulin sensitivity, linking the gut-liver axis to obesity and type 2 diabetes. These findings may guide development of microbiome-targeted therapies for metabolic disease.
Insulin resistance in polycystic ovary syndrome phenotypes and the vicious cycle model in its etiology
November 28, 2025 / PCOS phenotypes / Insulin resistance / Hyperandrogenism cycle / HOMA-IR analysis / Cardiometabolic risk
Insulin resistance is prevalent across all PCOS phenotypes, most severe in phenotype A, and correlates with androgen levels and cardiometabolic risk markers—supporting a “vicious cycle” model linking hyperinsulinemia and hyperandrogenism in PCOS pathophysiology.
Diabetic women are more prone to having cardiovascular diseases compared to men: Expert
December 2, 2025 / Type 2 diabetes / Cardiovascular risk / Diabetic women / Estrogen protection loss / PCOS complications
Women with Type 2 diabetes face significantly higher cardiovascular risks than men, due to loss of estrogen’s protective effects. This includes increased odds of coronary artery disease, stroke, dementia, and kidney disease, especially in women with PCOS.
Gut Microbiome Imbalance Linked to PCOS Symptoms
December 1, 2025 / PCOS microbiome / Gut dysbiosis / Short-chain fatty acids / Insulin resistance / Microbiota therapy
New research links gut microbiome dysbiosis and reduced short-chain fatty acids to worsened metabolic and reproductive symptoms in phlegm-dampness PCOS, highlighting the potential of microbiota-targeted therapies for improving insulin resistance and ovarian health.
Fanconi anemia patients show striking metabolic differences
November 29, 2025 / Fanconi anemia / Metabolic inflexibility / Insulin resistance / Cancer risk / Isotope metabolomics
Fanconi anemia patients show profound metabolic inflexibility, favoring fat over glucose metabolism and displaying insulin resistance—insights from isotope tracing metabolomics that may inform novel dietary strategies to reduce cancer risk and improve overall metabolic health.
Heat Waves Can Be Deadly for Seniors With Diabetes, Heart Disease
November 26, 2025 / Heatwave mortality / Cardiometabolic risk / Elderly diabetes patients / Urban heat islands / Climate health impact
Heatwaves significantly increase mortality risk in older adults with diabetes or heart disease, especially among those who are homeless or live in disadvantaged urban areas—highlighting the urgent need for targeted heat preparedness in vulnerable cardiometabolic populations.